CGTX - CIK 0001455365
The table below shows COGNITION THERAPEUTICS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $6.12M | $3.77M | $11.48M | $10.79M | $11.39M | $11.58M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.70M |
| $2.60M |
| $2.50M |
| $2.99M |
| $3.07M |
| $3.10M |
| Operating income | -$8.82M | -$6.38M | -$13.98M | -$13.78M | -$14.46M | -$14.68M |
| Income tax | - | - | - | - | - | - |
| Net income | -$4.57M | -$4.93M | -$6.73M | -$8.48M | -$9.94M | -$7.04M |
| EPS (diluted) | -$0.05 | -$0.06 | -$0.11 | -$0.14 | -$0.25 | -$0.18 |